|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
AU627226B2
(en)
|
1988-08-25 |
1992-08-20 |
Liposome Company, Inc., The |
Influenza vaccine and novel adjuvants
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
AU651949B2
(en)
|
1989-07-14 |
1994-08-11 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
GB2276169A
(en)
|
1990-07-05 |
1994-09-21 |
Celltech Ltd |
Antibodies specific for carcinoembryonic antigen
|
|
ATE128628T1
(de)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
DE69313134T2
(de)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
JP2002514886A
(ja)
*
|
1994-10-24 |
2002-05-21 |
プロメガ コーポレーション |
クロストリジウム・ディフィシル疾患の治療及び予防のためのワクチン及び抗トキシン
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
CA2226339A1
(en)
|
1995-07-07 |
1997-01-30 |
Oravax, Inc. |
Clostridium difficile toxins as mucosal adjuvants
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
EP1105153A4
(en)
|
1996-08-28 |
2005-01-19 |
Ophidian Pharm Inc |
POLYVALENT VACCINE AGAINST NEUROTOXIN (CLOSTRIDIUM BOTILINUM)
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
AU746859B2
(en)
*
|
1997-06-20 |
2002-05-02 |
Imperial College Of Science, Technology And Medicine |
Immonogenic fragments of toxin a of clostridium difficile
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
EP1279401B1
(en)
|
1997-09-05 |
2008-01-09 |
GlaxoSmithKline Biologicals S.A. |
Oil in water emulsions containing saponins
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
CN1200730C
(zh)
|
1998-02-12 |
2005-05-11 |
惠氏控股有限公司 |
用白细胞介素－12配制的肺炎球菌和脑膜炎球菌疫苗
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
BR9909915A
(pt)
|
1998-04-09 |
2000-12-26 |
Smithkline Beecham Biolog |
Composições adjuvantes
|
|
US20020009429A1
(en)
*
|
1999-01-29 |
2002-01-24 |
Galagen, Inc. |
Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
|
|
CA2366152A1
(en)
|
1999-03-19 |
2000-09-28 |
Smithkline Beecham Biologicals S.A. |
Streptococcus pneumoniae vaccine
|
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
US6733760B1
(en)
*
|
1999-04-09 |
2004-05-11 |
Techlab, Inc. |
Recombinant toxin A/toxin B vaccine against Clostridium difficile
|
|
EP1169456B1
(en)
|
1999-04-09 |
2012-07-11 |
Intercell USA, Inc. |
Recombinant production of Clostridium difficile Toxin A or Toxin B
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
AU2001258107A1
(en)
*
|
2000-05-10 |
2001-11-20 |
Glycodesign Inc. |
Designing modulators for glycosyltransferases
|
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
|
US20040107461A1
(en)
*
|
2001-03-30 |
2004-06-03 |
Padma Commuri |
Glucan chain length domains
|
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
|
EP1425040A2
(en)
|
2001-09-14 |
2004-06-09 |
Cytos Biotechnology AG |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
AU2003299527A1
(en)
|
2002-06-17 |
2004-06-07 |
Jimmy D. Ballard |
Mutant of clostridium difficile toxin b and methods of use
|
|
US20040235139A1
(en)
*
|
2002-12-23 |
2004-11-25 |
Demain Arnold L. |
Clostridium difficile culture and toxin production methods
|
|
ES2366626T3
(es)
|
2004-02-06 |
2011-10-24 |
University Of Massachusetts |
Anticuerpos contra toxinas de clostridium difficile y usos de los mismos.
|
|
CA2592015A1
(en)
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
|
US20060228369A1
(en)
|
2005-04-11 |
2006-10-12 |
Program For Appropriate Technology In Health |
Stabilization and preservation of temperature-sensitive vaccines
|
|
CN101500581B
(zh)
|
2006-06-08 |
2013-10-30 |
科内尔研究基金会 |
编码艰难梭菌毒素a和毒素b受体结合域的密码子优化dna分子及其使用方法
|
|
JP5345532B2
(ja)
|
2006-08-02 |
2013-11-20 |
ヨハネス・グーテンベルク−ウニヴェルジテート・マインツ |
Ｌｃｔ中毒に対する医薬品
|
|
EP2167119B1
(en)
*
|
2007-06-14 |
2016-08-24 |
The Secretary of State for Health |
Chemically modified peptides with improved immunogenicity
|
|
US8524444B2
(en)
*
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
|
WO2010017383A1
(en)
*
|
2008-08-06 |
2010-02-11 |
Emergent Product Development Uk Limited |
Vaccines against clostridium difficile and methods of use
|
|
US8709428B2
(en)
|
2009-02-20 |
2014-04-29 |
Health Protection Agency |
Antibodies to Clostridium difficile toxins
|
|
EP2470664A4
(en)
*
|
2009-08-27 |
2013-01-16 |
Synaptic Res Llc |
NEW PROTEIN RELEASE SYSTEM FOR GENERATING INDUCED PLURIPOTENTAL STEM CELLS OR TISSUE-SPECIFIC CELLS
|
|
WO2011060431A2
(en)
|
2009-11-16 |
2011-05-19 |
University Of Maryland Baltimore |
Multivalent live vector vaccine against clostridium difficile-associated disease
|
|
WO2011063346A1
(en)
|
2009-11-20 |
2011-05-26 |
Northshore University Health System Research Institute |
Targeting of the c-terminal segment of c. difficile toxin b for improved clinical diagnosis, prevention, and treatment
|
|
JP2013512916A
(ja)
|
2009-12-02 |
2013-04-18 |
タフツ ユニバーシティー |
免疫原としてのＣｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅの無毒の組換えホロトキシン
|
|
GB0921288D0
(en)
|
2009-12-04 |
2010-01-20 |
Health Prot Agency |
Therapies for preventing or suppressing clostridium difficile infection
|
|
WO2011126811A2
(en)
|
2010-03-30 |
2011-10-13 |
Pfenex Inc. |
High level expression of recombinant toxin proteins
|
|
AU2011239470B2
(en)
*
|
2010-04-15 |
2015-09-10 |
Progenics Pharmaceuticals, Inc. |
Antibodies for the treatment of Clostridium difficile-associated infection and disease
|
|
KR101907434B1
(ko)
|
2010-09-03 |
2018-10-12 |
발네바 오스트리아 게엠베하 |
C. 디피실의 a 독소 및 b 독소 단백질의 분리된 폴리펩타이드 및 이의 용도
|
|
US8431361B2
(en)
|
2010-09-17 |
2013-04-30 |
Board Of Regents Of The University Of Oklahoma |
Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant Clostridium difficile toxin B
|
|
GB201016742D0
(en)
*
|
2010-10-05 |
2010-11-17 |
Health Prot Agency |
Clostridium difficile antigens
|
|
WO2012118693A1
(en)
|
2011-02-28 |
2012-09-07 |
Northshore University Healthsystem |
Methods of diagnosing clostridium difficile infection
|
|
AR086199A1
(es)
*
|
2011-04-22 |
2013-11-27 |
Wyeth Llc |
Composiciones relacionadas con una toxina de clostridium difficile mutante y sus metodos
|
|
US9290565B2
(en)
|
2011-05-27 |
2016-03-22 |
Glaxosmithkline Biologicals, S.A. |
Immunogenic composition
|
|
AR087716A1
(es)
*
|
2011-08-31 |
2014-04-09 |
Valent Biosciences Corp |
Composiciones reguladoras del crecimiento de plantas, metodos de preparacion y usos de las mismas
|
|
AR089797A1
(es)
*
|
2012-01-27 |
2014-09-17 |
Merck Sharp & Dohme |
Vacunas contra clostridum difficile que comprenden toxinas recombinantes
|
|
GB201223342D0
(en)
*
|
2012-12-23 |
2013-02-06 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|